OME Omega Protein Corporation

OME Investors: GPM Reminds Investors of the May 2 Deadline in the Class Action Lawsuit Against Omega Protein Corporation

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the May 2, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Omega Protein Corporation (“Omega” or the “Company”) (NYSE: OME) securities between June 4, 2013 and March 1, 2017, inclusive (the “Class Period”). Omega investors have until May 2, 2017 to file a lead plaintiff motion.

On March 1, 2017, the Company disclosed that it had received a subpoena from the SEC seeking information in connection with an investigation of an Omega subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees.

On this news shares of Omega Protein fell by over 20%, or $5.50 per share, during intra-day trading on March 2, 2017.

The complaint filed in this action alleges that the Company made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that Omega’s subsidiary was potentially not in compliance with its probation terms; (2) that the Company was not properly protecting whistleblower employees; (3) that, as a result of the foregoing, the Company was vulnerable to an SEC investigation and potential civil and criminal liability; and (4) that, as a result of the foregoing, Defendants’ statements about Omega’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

If you purchased or otherwise acquired Omega Protein shares during the Class Period you may move the Court no later than May 2, 2017 to request appointment as lead plaintiff. To be a member of the class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

EN
27/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Omega Protein Corporation

A director sold 13,738 shares at 22.000USD and

A director at Omega Protein Corp sold 13,738 shares at 22.000USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

 PRESS RELEASE

The Law Offices of Vincent Wong Notifies Investors of an Investigation...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Omega Protein Corporation (NYSE: OME) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Cooke Inc. Under the terms of the deal, Omega Protein shareholders will receive $22.00 for each share of Omega Protein stock they own. The investigation concerns whether the Omega Protein Board of Directors breached their fiduciary duties to Omega Protein stockholders ...

 PRESS RELEASE

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Omega Protein Corporation (“Omega Protein” or the “Company”) (NYSE:OME) stock prior to October 6, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Omega Protein to Cooke Inc. for $22.00 per share. To learn more about the action and your rights, go to: http://www.zlkdocs.com/OME-Info-Request-Form-m...

 PRESS RELEASE

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Omega Protein Corporation (“Omega Protein” or the “Company”) (NYSE: OME) stock prior to October 6, 2017. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Omega Protein to Cooke Inc. for $22.00 per share. To learn more about the action and your rights, go to: http://www.zlkdocs.com/OME-Info-Request-Form-...

 PRESS RELEASE

OMEGA PROTEIN CORPORATION SHAREHOLDER ALERT: Former SEC Attorney Willi...

DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Omega Protein Corporation (“Omega Protein”) (NYSE: OME) concerning the acquisition by Cooke Inc. Under the terms of the agreement, valued at approximately $500 million, Omega Protein shareholders will only receive $22.00 per Omega Protein share owned. The consideration is significantly lower than at least one analyst’s estimated value of $26.00. If...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch